NASDAQ:CFRX - Nasdaq - US2123264093 - Common Stock - Currency: USD
TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 39.32M | 58.49M | 47.27M | 34.24M | 27.87M | |||
Research and Development | 32.87M | 53.30M | 46.06M | 26.81M | 21.66M | |||
Selling, General, and Administrative Expenses | 12.31M | 12.15M | 11.76M | 11.63M | 9.81M | |||
Operating Income | -39.32M | -58.49M | -47.27M | -34.24M | -27.87M | |||
Interest Income/Expense | 230.00K | 80.00K | 110.00K | 190.00K | 360.00K | |||
Other Income/Expense | 3.26M | -6.73M | 26.87M | 5.89M | 14.71M | |||
Non Recurring Items | N/A | -20.00K | N/A | N/A | N/A | |||
Income Before Taxes | -35.85M | -65.15M | -20.28M | -28.16M | -12.79M | |||
Net Income | -35.85M | -65.15M | -20.28M | -28.16M | -12.79M | |||
EBITDA | -39.17M | -58.34M | -47.12M | -34.07M | -27.70M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -53.58 | -125.28 | -44.08 | -100.57 | -127.90 | |||
Non GAAP EPS | -37.17 | -112.14 | -30.58 | -1.48 | -1.41 | |||
Statistics |
All data in USD